Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
Abstract
Purpose: Sexual dysfunction in patients with schizophrenia can reduce quality of life and treatment compliance. This report will compare the effects of selected atypical and typical antipsychotics on sexual function in a large, international population of outpatients with schizophrenia who were treated over 1 year. Subjects and methods: Outpatients with schizophrenia, who initiated or changed antipsychotic treatment, and entered this 3-year, prospective, observational study were classified according to the monotherapy prescribed at baseline: olanzapine (N = 2638), risperidone (N = 860), quetiapine (N = 142) or haloperidol (N = 188). Results: Based on patient perception, the odds of experiencing sexual dysfunction during 1 year of therapy was significantly lower for patients treated with olanzapine and quetiapine when compared to patients who received risperidone or haloperidol (all P ≤ 0.001). Females on olanzapine (14%) or quetiapine (8%) experienced a lower rate of menstrual irregularities, compared to females on risperidone (23%) or haloperidol (29%). Significant discordance was evident between patient reports and psychiatrist perception of sexual dysfunction, with psychiatrists underestimating sexual dysfunction (P ≤ 0.001). Conclusions: These findings indicate clinically relevant differences exist in the sexual side effect profiles of these selected antipsychotics. These factors should be considered when selecting the most appropriate treatment for outpatients with schizophrenia.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Only few studies have directly compared the sexual functioning associated with different atypical antipsychotics.
“To date, only few studies (534-547) have directly compared the sexual functioning associated with different atypical AP.”
From Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) · cites this paper as [539]
Cites
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705 · see citing works
Arvanitis, L. A., & Miller, B. G. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00190-x · Cited by 806 · see citing works
Trân, P. V., Hamilton, S. H., Kuntz, A. J., Potvin, J. H., Andersen, S. W., Beasley, C. M., & Tollefson, G. D. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199710000-00010 · Cited by 712 · see citing works
Predictors of Noncompliance in Patients With Schizophrenia
Perkins, D. O. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1206 · Cited by 546 · see citing works
Kinon, B. J., Gilmore, J. A., Liu, H., & Halbreich, U. M. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00127-0 · Cited by 350 · see citing works
Prolactin Levels and Adverse Events in Patients Treated with Risperidone
Kleinberg, D. L., Davis, J. M., Coster, R. D., van Baelen, B., & Brecher, M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00011 · Cited by 307 · see citing works
Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects
Halbreich, U. M., Kinon, B. J., Gilmore, J. A., & Kahn, L. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00112-9 · Cited by 250 · see citing works
Compliance with antipsychotic drug treatment: influence of side effects
Ww, F., Meise, U., Günther, V., & Kurz, M. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb05859.x · Cited by 241 · see citing works
David, S. R., Taylor, C. C., Kinon, B. J., & Breier, A. F. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80086-7 · Cited by 236 · see citing works
Sexual Dysfunction and Plasma Prolactin Levels in Neuroleptic-treated Schizophrenic Outpatients
GHADIRIAN, A. M., Chouinard, G., & Annable, L. (1982) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198208000-00004 · Cited by 225 · see citing works
Sexual dysfunction in male schizophrenic patients.
Aizenberg, D., Zemishlany, Z., Dorfman-Etrog, P., & Weizman, A. (1995) · PubMed · Cited by 213 · see citing works
Bobes, J., A-PORTILLA, M. P. G., Rejas, J., ndez, G. H., García-García, M., Rico‐Villademoros, F., & PORRAS, A. (2003) · Journal of Sex & Marital Therapy · doi:10.1080/713847170 · Cited by 213 · see citing works
Volavka, J., Czobor, P., Cooper, T. B., Sheitman, B., Lindenmayer, J., Citrome, L., McEvoy, J. P., & Lieberman, J. A. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0109 · Cited by 201 · see citing works
What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?
Knegtering, H., van der Moolen, A. E. G. M., Castelein, S., Kluiter, H., & van den Bosch, R. J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00130-0 · Cited by 196 · see citing works
Sexual dysfunction and antipsychotic treatment
Cutler, A. J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00113-0 · Cited by 176 · see citing works
Neuroleptic-induced hyperprolactinemia
Dickson, R. A. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00159-5 · Cited by 148 · see citing works
Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences.
Maguire, G. A. (2002) · PubMed · Cited by 119 · see citing works
Dossenbach, M., Hodge, A., Anders, M., Molnár, B., Peciukaitiene, D., Krupka-Matuszczyk, I., Tatu, M., Bondar, V., Pecenak, J., Gorjanc, T., et al. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704005012 · Cited by 106 · see citing works
Self-citationKim, K., Pae, C., Chae, J., Bahk, W., Jun, T.-Y., Kim, D., & Dickson, R. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0506 · Cited by 104 · see citing works
Sexual histories, attitudes, and behavior of schizophrenic and ?normal? women
Friedman, S., & Harrison, G. (1984) · Archives of Sexual Behavior · doi:10.1007/bf01542090 · Cited by 96 · see citing works
Dossenbach, M., Erol, A., Kessaci, M. E. M., Shaheen, M. O., Sunbol, M. M., Boland, J., Hodge, A., O'Halloran, R. A., Bitter, I., & IC-SOHO Study Group (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0305 · Cited by 80 · see citing works
Self-citationSexual dysfunction: the unspoken side effect of antipsychotics
Peuskens, J., Sienaert, P., & De Hert, M. (1998) · European Psychiatry · doi:10.1016/s0924-9338(98)82005-1 · Cited by 80 · see citing works
Hormonal side effects in women: typical versus atypical antipsychotic treatment.
Dickson, R. A., Seeman, M. V., & Corenblum, B. (2000) · PubMed · Cited by 79 · see citing works
Sexual behavior and sexual problems among patients with severe chronic psychoses
Raja, M., & Azzoni, A. (2003) · European Psychiatry · doi:10.1016/s0924-9338(03)00009-9 · Cited by 73 · see citing works
Sexual dysfunction: The unspoken side effect of antipsychotics
Peuskens, J., Sienaert, P. A., & Hert, M. D. (1998) · European Psychiatry · doi:10.1016/s0924-9338(97)89490-4 · Cited by 72 · see citing works
Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia
Meaney, A. M., & O’Keane, V. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01775-7 · Cited by 64 · see citing works
Sacristán, J. A., Gómez, J., Montejo, A. L., Vieta, E., & Gregor, K. J. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80046-6 · Cited by 54 · see citing works
Sexual Side Effects Associated With Conventional and Atypical Antipsychotics
Compton, M. T., Miller, A. H., Miller, A. A. H., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4256 · Cited by 42 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488 · see citing works
Women’s sexual dysfunction associated with psychiatric disorders and their treatment
Basson, R., & Gilks, T. (2018) · Women's Health · doi:10.1177/1745506518762664 · Cited by 225 · see citing works
Sexual dysfunction in schizophrenia: focus on recent evidence
Baggaley, M. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.924 · Cited by 191 · see citing works
The Impact of Mental Illness on Sexual Dysfunction
Zemishlany, Z., & Weizman, A. (2008) · Advances in Psychosomatic Medicine · doi:10.1159/000126626 · Cited by 188 · see citing works
Hanssens, L., L'Italien, G., Loze, J.-Y., Marcus, R. N., Pans, M., & Kerselaers, W. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-95 · Cited by 85 · see citing works
Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
Taylor, R. W., Marwood, L., Oprea, E., DeAngel, V., Mather, S., Valentini, B., Zahn, R., Young, A. H., & Cleare, A. J. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa033 · Cited by 76 · see citing works
Konarzewska, B., Wołczyński, S., Szulc, A., Galińska, B., Popławska, R., & Waszkiewicz, N. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.08.015 · Cited by 70 · see citing works
Sexual dysfunction in schizophrenia
Malik, P. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328017f6c4 · Cited by 54 · see citing works
Sexual problems in schizophrenia: prevalence and characteristics. A cross sectional survey
Harley, E. W.-Y., Boardman, J., & Craig, T. (2010) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-009-0119-0 · Cited by 52 · see citing works
Berwaerts, J., Cleton, A., Rossenu, S., Talluri, K., Remmerie, B., Janssens, L., Boom, S., Kramer, M., & Eerdekens, M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106914 · Cited by 49 · see citing works
- Authors
- Dossenbach, M., Dyachkova, Y., Pirildar, S., Anders, M., Khalil, A., Araszkiewicz, A., Shakhnovich, T., Akram, A., Pecenak, J., McBride, M., & Treuer, T.
- Affiliations
- Charles University (CZ)
- Ain Shams University Hospital (EG)
- Soliman Fakeeh Hospital (SA)
- Eli Lilly (Australia) (AU)
- Corresponding author
- Dossenbach, Martin
- Venue
- European Psychiatry
- Publisher
- Cambridge University Press (CUP)
- Published
- 2006-06
- Volume
- 21
- Issue
- 4
- Pages
- 251-258
- ISSN
- 0924-9338 (ISSN-L)
- 1778-3585
- OpenAlex
- W2038782032
- Cited by
- 121
- References
- 28
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 9 · 2018: 1 · 2017: 6 · 2016: 6 · 2015: 5 · 2014: 4 · 2013: 5 · 2012: 11
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, sexual dysfunction, antipsychotic drugs, atypical antipsychotics, typical antipsychotics, olanzapine, risperidone, quetiapine, haloperidol, menstrual irregularity, patient-reported outcomes, physician perceptions, outpatients, treatment side effects
- MeSH terms
- Quetiapine Fumarate, Olanzapine, Adult, Analysis of Variance, Benzodiazepines, Dibenzothiazepines, Female, Haloperidol, Health Surveys, Humans, Male, Outpatients, Prospective Studies, Schizophrenia, Sexual Dysfunction, Physiological, Time, Antipsychotic Agents, Prevalence, Odds Ratio, Treatment Outcome, Risperidone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review